Loading ...

chlorhexidine-containing superhydrophobic coating

Based on

1 Patents
2011 Most recent source

Composition

1

polycaprolactone

PCL
Type Polymer
Formula
Role layer
2

cyclosporine A

CsA
Type Biomolecule
Formula
Role loaded material
3

poly (polyisobutylene/polyisobutylene/C40H46O9/C40H46O9)

Type Polymer
Formula
Role layer
4

CAB-O-SIL® TS-720 silica nanoparticl

AEROXIDE LE3 nanoparticles silica nanoparticles LE3 nanoparticles
Type Nano Material
Formula
Role fillers

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
controlled release drug delivery

More information/entries available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
coatings

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Chemical synthesis
Source:
Starting materials
  • polycaprolactone
  • cyclosporine A
  1. COKZd0rg5LGLbNApUW2Wn3cvF
Product

chlorhexidine-containing superhydrophobic coating

Size: not specified

Medium/Support: none

Method 2

Type: Chemical synthesis
Source:
Starting materials
  • polycaprolactone
  • cyclosporine A
  1. ROEoJObGxNxCfnEa1eiubHJsY
Product

chlorhexidine-containing superhydrophobic coating

Size: not specified

Medium/Support: none

Method 3

Type: Chemical synthesis
Source:
Starting materials
  • polycaprolactone
  • cyclosporine A
  1. 3KNAkciq65cs6UryNmySxGj8R
Product

chlorhexidine-containing superhydrophobic coating

Size: not specified

Medium/Support: none

Method 4

Type: Chemical synthesis
Source:
Starting materials
  • polycaprolactone
  • cyclosporine A
  1. YsAbxUAvmcREfBBhHgfgA3RGQ
Product

chlorhexidine-containing superhydrophobic coating

Size: not specified

Medium/Support: none

Method 5

Type: Chemical synthesis
Source:
Starting materials
  • polycaprolactone
  • cyclosporine A
  1. COnFoAqHTXN1wQrCxW6id6EIr
Product

chlorhexidine-containing superhydrophobic coating

Size: not specified

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:


Sign up for a free trial